What Is the Diabetes Weight Loss Drug? (October 2026)

01 · The answer

So which drug is it?

The name you are looking for depends on where you heard it, because several different medicines are described this way. The one we supply is Mounjaro, the brand name for tirzepatide, a once-weekly injectable prescription medicine made by Eli Lilly. In the UK it is licensed for weight management in adults and for type 2 diabetes.¹ It comes as a pre-filled multi-dose pen (KwikPen) in six strengths: 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg and 15mg.¹

Other names you will meet are Wegovy and Ozempic, which are brands of semaglutide, and Saxenda, which is liraglutide. Liraglutide is supplied at 6mg/ml and is a daily injection, unlike once-weekly Mounjaro and Wegovy.¹⁸

02 · What next

Is this relevant to you, and what should you do?

It is relevant if you have a weight-related health concern, or if you live with diabetes and want to understand your options. The first step is a conversation with a prescriber, not a purchase. Mounjaro is a prescription-only medicine, supplied only after an online consultation reviewed by a GPhC-registered prescriber. It is used alongside a reduced-calorie diet and increased physical activity. Individual results vary.¹

If you already have diabetes, do not start, stop or swap any medicine on your own. Your diabetes team knows your blood sugar history and other treatments, and some diabetes medicines may need their doses reviewed when another treatment is added. Our diabetes medication and weight loss guide goes into this in more depth.

If you do not have diabetes but want weight management treatment, the licensed route is the weight management indication. Our weight loss clinic explains how our service works, and you can read the plain-English version of how the treatment is used in our guide to a weight loss drug like Mounjaro online in the UK.

03 · Cost

A note on cost

Private treatment is paid for by you. Your first Mounjaro 2.5mg pen costs £129.99 as a first-order price with code FIRST40 (standard price £169.99), and every later order is £25 off the standard price. All doses are in stock. For a wider look at what people pay, see our page on the lowest Mounjaro price in the UK and the diabetes weight loss drug cost guide.

04 · Why several names

Why one question has several answers

The phrase diabetes weight loss drug is a popular shorthand rather than a medical category. It grew out of the fact that a group of injectable medicines first became known through diabetes care, and then people noticed and researchers studied their effect on appetite and body weight. Today some of these medicines hold a licence for diabetes, some for weight management, and some for both.

The easiest way to untangle it is to separate three things: the active ingredient, the brand name and the licence. The active ingredient is the chemical, such as tirzepatide, semaglutide or liraglutide. The brand is the product name on the box, such as Mounjaro, Wegovy, Ozempic or Saxenda. The licence is what the UK regulator has approved the product for, and it decides who can be prescribed it and why.

Mounjaro is the brand name for tirzepatide, a once-weekly injectable prescription medicine made by Eli Lilly. In the UK it is licensed for weight management in adults and for type 2 diabetes.¹

Wegovy is semaglutide at doses built for weight management. Its pens are 0.25mg, 0.5mg, 1mg, 1.7mg and 2.4mg once weekly; titration steps up after at least four weeks, reaching the 2.4mg maintenance dose from week 17, and the 2.4mg dose is the licensed maintenance dose for weight management.¹⁸ Ozempic is another semaglutide brand that people often mention in the same breath. The practical point is that brand and licence matter: you should be prescribed the product that matches your clinical situation, not the one that is most talked about.

Liraglutide, sold as Saxenda and in products such as Erly, is the older, daily option. It is supplied at a concentration of 6mg per millilitre, and it is a daily injection, unlike once-weekly Mounjaro and Wegovy.¹⁸ For some people a daily routine is perfectly fine; for others a weekly pen is easier to live with.

For a direct naming guide, see what the diabetes weight loss drug is called.

05 · How it works

How the medicine works in the body

Tirzepatide is the first treatment of its kind to activate two natural gut-hormone receptors at once: GIP and GLP-1.¹ Together these help regulate appetite, slow how quickly the stomach empties, and improve the way the body responds to insulin.¹ In practice, most people feel fuller sooner and less hungry between meals, which supports a reduced-calorie diet.¹

This dual action is what distinguishes Mounjaro from single-action GLP-1 medicines such as semaglutide (Wegovy/Ozempic).¹ Individual results vary, and your prescriber will decide what suits your health and other medicines.

It helps to understand why these effects matter for both diabetes and weight. Insulin is the hormone that moves sugar out of the blood. When the body responds to insulin better, blood sugar control improves, which is the reason these medicines were first developed for diabetes. Feeling full sooner and being less hungry between meals is the reason they are also used for weight management. The two effects come from the same family of gut hormones, so one medicine can serve both purposes.

Slower stomach emptying is also the reason for the contraception caution: the medicine can reduce how well oral contraceptive pills are absorbed.⁷ The SmPC advises switching to a non-oral method, or adding a barrier method (such as condoms), for 4 weeks after starting Mounjaro and for 4 weeks after each dose increase.¹ If you use an oral contraceptive, your prescriber can advise; the action is to switch to a non-oral method or add a barrier method for 4 weeks after starting and after each dose increase.

A weekly schedule is possible because the medicine stays in the body for a long time. Tirzepatide has a half-life of about five days, so after a final dose it takes roughly 4–5 weeks to clear the system — there is no way to speed this up, and nothing needs doing while it clears.¹ This is useful to know if you are planning a break, a change of treatment or a medical procedure; mention it to your prescriber.

It also explains why doses are raised gradually rather than quickly. The body needs time to adjust, so treatment starts at the lowest strength and your prescriber reviews you before any step up. Our guide on how Mounjaro works in diabetes covers the mechanism with a diabetes focus, and the pen instructions that come with every order show you how to inject correctly.

06 · Diabetes and Mounjaro

Mounjaro if you have diabetes

Mounjaro is also licensed for type 2 diabetes, where it improves blood sugar control (HbA1c) and supports weight loss.⁸ If you have type 2 diabetes, treatment and monitoring are coordinated differently — tell your prescriber and your usual diabetes team so care stays joined up.⁸

Why does coordination matter so much? Diabetes care is more than a single prescription. It includes blood sugar monitoring, regular reviews, eye and foot checks, and other medicines that may interact with how a new treatment affects your blood sugar. If a new medicine arrives without your diabetes team knowing, nobody is watching the whole picture. That is a safety gap that is easy to avoid by simply telling everyone involved.

One specific point worth knowing: doses of insulin or sulfonylureas may need adjusting when another treatment that lowers blood sugar is added, because of the risk of low blood sugar. That is not the same as saying these medicines must never be combined. It means your prescriber and diabetes team should decide on any change, and you should not alter your doses yourself. If you are unsure what low blood sugar feels like, ask your diabetes nurse before starting anything new.

Many people with diabetes are prescribed a gut-hormone medicine on the NHS for the diabetes indication. Others, particularly those whose main goal is weight management, look at the weight management route. The two routes have different eligibility rules, and a clinician will explain which applies to you. Our wider guide to diabetes medication and weight loss sets out the practical questions to ask your team.

Many readers also arrive here asking how to stop weight loss in diabetes. If you are losing weight without trying, that deserves a medical review rather than a home fix, because unintended weight loss in diabetes can have several causes. If you are on one of these injections and your weight is falling faster than you or your prescriber expected, tell your prescriber so your plan can be reviewed.

Finally, report any side effect you think may be linked to a medicine through the Yellow Card scheme, which is run by the MHRA.¹⁹ Reports help regulators spot patterns, and anyone can make one.

07 · NHS or private

NHS or private: how access works

Mounjaro is available on the NHS, but access is being phased in over several years.⁶ NICE recommends it for adults with a BMI of at least 35 plus at least one weight-related condition, and the NHS primary-care rollout began in June 2025 with the highest-need groups first (initially BMI 40+ with four or more qualifying conditions).⁴⁶ Full rollout is expected to take years, which is why many people who meet the licensed criteria choose regulated private treatment rather than waiting.⁶

For people with diabetes, the NHS route for the diabetes licence is a separate pathway from the weight management one, and your GP or diabetes team is the right place to ask what applies to you. For weight management, ask your GP about the current local position, as phasing means availability can differ from one area to another.

A frequent question is whether insurance covers these medicines. Private prescriptions are generally paid for by the patient, and whether any private health insurance policy contributes depends entirely on the policy wording, so check with your insurer directly. We do not make claims on behalf of insurers.

What does private treatment involve with us? It starts with a free online consultation, which is a short health questionnaire with no charge and no obligation. A GPhC-registered prescriber reviews your answers, not a scoring script. Payment is taken when you place the order; if the prescriber decides the treatment is not suitable, the order is refunded automatically in full. Once approved, the medicine is dispensed by our registered pharmacy, with same-day dispatch when ordered by 3pm and free next-day tracked delivery in temperature-controlled, discreet packaging.

It is worth being honest about the trade-off. The NHS route costs nothing at the point of use beyond usual NHS rules, but you may wait. Private treatment is faster for people who meet the licensed criteria, but you pay for the medicine. Neither is right for everyone, and you can always speak to your GP first. Our page on the weight loss drug shortage covers supply questions you might have along the way.

Whichever route you choose, the clinical basics are the same: the medicine is used alongside a reduced-calorie diet and increased physical activity, results vary, and ongoing review matters. Our aftercare includes monthly reviews, dose titration and follow-up assessments by the prescribing team, plus side-effect support.

08 · Other medicines compared

Mounjaro, semaglutide and liraglutide compared

Tirzepatide acts on both GIP and GLP-1 receptors, while semaglutide is described as a single-action GLP-1 medicine.¹ Liraglutide is also a daily injection supplied at 6mg/ml, which sets it apart from the weekly pens.¹⁸

Frequency is the most obvious practical difference. A weekly pen means one injection day to remember. A daily injection means a routine every day, which some people find easier to keep consistent and others find tiring. Neither is wrong; it comes down to preference and what your prescriber recommends.

Dose steps are the second difference. Wegovy has its own ladder from 0.25mg to 2.4mg, stepping up after at least four weeks and reaching the maintenance dose from week 17. These are different scales for different molecules, so a number on one cannot be compared with a number on the other. A 5mg tirzepatide pen is not equivalent to a 0.5mg semaglutide pen.

Evidence is the third. Each medicine has its own clinical trials, and results from one trial cannot be laid next to another's as if they were head to head.

Oral options also exist, such as Wegovy tablets and Foundayo. Prices change, so see current Wegovy tablet prices on the relevant product page rather than relying on estimates.

There is no universally correct answer. The better question is which licensed option suits your health, your other medicines and your day-to-day life. A prescriber who can see your history is the person to decide, and our new diabetes drug for weight loss page tracks the newer names appearing in the news.

09 · Stopping and long term

Stopping, side effects and the long term

Mounjaro manages weight; it does not cure the biology behind it. In SURMOUNT-4, people who stopped tirzepatide after 36 weeks regained on average 14% of body weight over the following year, while those who continued treatment lost a further 5.5% on average.¹⁴ Tirzepatide also has a half-life of about five days, so after a final dose it takes roughly 4–5 weeks to clear the system — there is no way to speed this up, and nothing needs doing while it clears.¹

Talk to your prescriber before you stop. They can help you think about a gradual change, what support to put in place, and whether ongoing treatment remains right for you.

Going off Mounjaro does not require any special action from you while it clears, but if you have diabetes the more important issue is blood sugar. Stopping a diabetes medicine without a plan can affect your blood sugar control, so speak to your diabetes team first.

Like all medicines, Mounjaro can cause side effects, and most are digestive: the most common, affecting more than 1 in 10 people, are nausea, diarrhoea, vomiting, constipation and abdominal discomfort.¹³ For long-term side effects, the honest position is that your prescriber reviews you regularly, the leaflet and the SmPC set out what is known, and the Yellow Card scheme exists so new concerns can be reported.¹⁹

If you notice something new, such as an unusual symptom you have not seen in the leaflet, tell your prescriber. If it is not a listed side effect, it still deserves a conversation, and you can report it through Yellow Card.

What should you avoid while taking Mounjaro? Avoid the things the leaflet tells you to avoid, and do not use leftover pens, share pens or change your dose without your prescriber. If you are unsure about alcohol, food or other medicines, ask your prescriber and read the leaflet.

Keep pens in the fridge at 2–8°C and never freeze them. Once in use, a pen can be kept out of the fridge at a temperature not above 30°C for up to 30 days after first use, and must then be thrown away.¹³

10 · Serious side effects

Serious side effects: when to get help straight away

Serious side effects are uncommon but need urgent attention. Seek immediate medical help for: severe, persistent stomach pain that may spread to your back, with or without vomiting (possible pancreatitis); pain in the upper right abdomen, fever or yellowing of skin/eyes (possible gallbladder problems); or signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing. If you take insulin or a sulfonylurea alongside Mounjaro, watch for low blood sugar (shakiness, sweating, confusion) — your prescriber may need to adjust those medicines.¹

11 · Safe supply and ordering

Buying safely and how ordering works

Because these medicines are in high demand, counterfeit and unregulated products are a real risk. The MHRA publishes counterfeit medicine alerts and runs the Yellow Card scheme.⁷ Be wary of anyone offering to supply without a consultation or prescription, of unusually low prices, and of sellers who promise specific results or use dramatic weight-loss claims. A prescription-only medicine should only come from a registered pharmacy after a proper review.

You can check a pharmacy yourself on the public register of pharmacies and pharmacy professionals kept by the GPhC.¹² EverydayMeds is a GPhC-registered UK online pharmacy, registration 9012878. We supply Mounjaro through official LillyDirect supply, direct from Eli Lilly's UK distribution, with genuine KwikPens and all doses stocked.

• Free online consultation. A short health questionnaire, no charge and no obligation.
• Prescriber review. A GPhC-registered prescriber reviews your answers. Payment is taken when you place the order; if the prescriber decides the treatment is not suitable, the order is refunded automatically in full.
• Dispensing and delivery. Our registered pharmacy dispenses your order, with same-day dispatch when ordered by 3pm. Delivery is free next-day tracked in temperature-controlled, discreet packaging; Saturday delivery is £14.99.

The consultation is free and the price shown is the price paid, with no hidden fees. Needles, a sharps bin and injection guidance are included with every order. You can pay by Visa or Mastercard, Klarna or pay-monthly options, and there are no subscriptions. Repeat orders re-check suitability, so nothing is shipped automatically.

If you have questions, our support team is available Monday to Friday, 9am to 5pm, by email at support@everydaymeds.co.uk, through the account portal chat or by phone. We also offer GLPTrackr, a free companion app for tracking your journey on iOS and Android.

When you are ready, the Mounjaro pen page shows current prices and starts the consultation.